Patents by Inventor Alexes Daquinag

Alexes Daquinag has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230056203
    Abstract: Methods and compositions are presented for use in diagnostic, imaging or targeting of therapeutic agents to treat cancer cells in metastases. such as where compositions and methods identify and employ peptides to selectively target cancer cells in metastases in mammals, both in vitro and in vivo.
    Type: Application
    Filed: August 12, 2022
    Publication date: February 23, 2023
    Applicant: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
    Inventors: Mikhail KOLONIN, Alexes DAQUINAG, Shraddha SUBRAMANIAN
  • Patent number: 9539341
    Abstract: Methods and compositions are presented for use in diagnostic, imaging or targeting of therapeutic agents to treat obesity/adiposity-associated disorders, compositions and methods identify and use peptides to selectively target adipose tissue stromal cells in mammals.
    Type: Grant
    Filed: April 9, 2015
    Date of Patent: January 10, 2017
    Assignee: BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
    Inventors: Mikhail G. Kolonin, Alexes Daquinag, Yan Zhang
  • Publication number: 20160000930
    Abstract: Methods and compositions are presented for use in diagnostic, imaging or targeting of therapeutic agents to treat obesity/adiposity-associated disorders, compositions and methods identify and use peptides to selectively target adipose tissue stromal cells in mammals.
    Type: Application
    Filed: April 9, 2015
    Publication date: January 7, 2016
    Inventors: Mikhail G. KOLONIN, Alexes DAQUINAG, Yan ZHANG
  • Patent number: 9029321
    Abstract: Methods and compositions are presented for use in diagnostic, imaging or targeting of therapeutic agents to treat obesity/adiposity-associated disorders, where such as compositions and methods identify and use peptides to selectively target adipose tissue stromal cells in mammals, both in vitro and in vivo.
    Type: Grant
    Filed: March 30, 2012
    Date of Patent: May 12, 2015
    Assignee: Board of Regents of the University of Texas
    Inventors: Mikhail G. Kolonin, Alexes Daquinag, Yan Zhang
  • Publication number: 20140243258
    Abstract: Methods and compositions are presented for use in diagnostic, imaging or targeting of therapeutic agents to treat obesity/adiposity-associated disorders, where such as compositions and methods identify and use peptides to selectively target adipose tissue stromal cells in mammals, both in vitro and in vivo.
    Type: Application
    Filed: March 30, 2012
    Publication date: August 28, 2014
    Applicant: The Board of Regents of the University of Texas System
    Inventors: Mikhail G. Kolonin, Alexes Daquinag, Yan Zhang